Addex Therapeutics Ltd (ADXN) — Cash Flow Reinvestment Rate

Latest as of December 2020: 0.14x

Addex Therapeutics Ltd (ADXN) has a Cash Flow Reinvestment Rate of 0.14x as of December 2020, reinvesting $96.17K (capex $48.09K plus investments $-48.09K) from operating cash flow of $704.85K. Check Addex Therapeutics Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.14x
(Capex + Investments) / Operating CF

Total Reinvested

$96.17K
Capex + Investments

Operating Cash Flow

$704.85K
USD

Capital Expenditures

$48.09K
USD

Addex Therapeutics Ltd Cash Flow Reinvestment Rate (2018–2018)

Historical reinvestment intensity for Addex Therapeutics Ltd across 1 annual periods. Explore ADXN long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Addex Therapeutics Ltd (2018–2018)

Year-by-year capital reinvestment analysis for Addex Therapeutics Ltd. For live market cap and broader valuation context, see Addex Therapeutics Ltd (ADXN) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2018 0.03x $56.37K $1.75 Million $9.05K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow